Akademik Veri Yönetim Sistemi
Cardiovascular and Interventional Radiological Society of Europe 2024, Lisbon, Portekiz, 14 - 18 Eylül 2024, ss.1404, (Tam Metin Bildiri)
Learning Objectives
To evaluate imaging-guided percutaneous and angiographic interventions for the diagnosis and treatment of
adrenal gland diseases, together with current indications and technical details.
Background
Minimally invasive methods used for adrenal lesions include percutaneous biopsy (PB) and adrenal venous
sampling (AVS) for diagnosis and percutaneous ablation (PA) and adrenal artery embolization (AAE) for
treatment.
Procedure Details
PB is performed when malignancy cannot be ruled out by imaging or when molecular profiling is required for
treatment decision. In the procedure, coaxial technique is often used and fine needle aspiration biopsy or core
biopsy is taken. AVS aims to take blood samples directly from the adrenal veins. The main indication is to
differentiate between an aldosterone-secreting adenoma and idiopathic hyperaldosteronism by comparing
the amount of hormone produced in both adrenal glands in the case of primary hyperaldosteronism. PA
methods include radiofrequency ablation, cryoablation, microwave ablation, chemical ablation, and
irreversible electroporation. It is indicated for patients who refuse surgery or who have comorbidities. It can
be used for all benign and malignant pathologies of the adrenal gland. AAE is used in oncological applications
such as pain relief, tumor debulking, and preoperative reduction of tumor vascularity, as well as for the
treatment of hyperaldosteronism, post-traumatic hemorrhage, and adrenal artery aneurysm. Coils, polyvinyl
alcohol, and gelatin sponge particles are frequently used agents for embolization.
Conclusion
Minimally invasive methods performed under imaging guidance can be used safely for the diagnosis or
treatment of benign and malignant adrenal gland diseases if indicated.